VERU
USDVeru Inc. Common Stock
$0.653-0.007 (-1.061%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$0.660
最高
$0.685
最低
$0.612
交易量
1.69M
公司基本面
市值
95.7M
行業
生物科技
國家
United States
交易統計
平均交易量
2.33M
交易所
NCM
貨幣
USD
52週範圍
最低 $0.45當前 $0.653最高 $1.42
相關新聞
GlobeNewswire
Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone
--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial efficacy and
查看更多
GlobeNewswire
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress
--Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of
查看更多
